ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · IEX Real-Time Price · USD
107.32
+4.43 (4.31%)
At close: Mar 28, 2024, 4:00 PM
107.24
-0.08 (-0.07%)
After-hours: Mar 28, 2024, 6:26 PM EDT

ICU Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Net Income
-29.66-74.29103.1486.87101.0428.7968.6463.0844.9926.34
Upgrade
Depreciation & Amortization
250.68258.899.2994.8585.2174.7466.5719.0518.0719.45
Upgrade
Share-Based Compensation
40.5636.0327.3423.9521.9224.2419.3515.2412.839.59
Upgrade
Other Operating Activities
-95.39-282.6737.7717.08-106.2532.45-0.14-7.44-11.6910.97
Upgrade
Operating Cash Flow
166.2-62.13267.54222.75101.92160.22154.4289.9464.266.34
Upgrade
Operating Cash Flow Growth
--20.11%118.56%-36.39%3.75%71.69%40.11%-3.23%0.93%
Upgrade
Capital Expenditures
-92.17-98.34-80.95-94.21-106.01-100.01-79.68-24.55-10.34-17.59
Upgrade
Acquisitions
0-1,844.16-14.450-76.13-1.3-162.45-2.58-27.820
Upgrade
Change in Investments
4.2233.044.72-3.9315.25-15.06-24.7440.1526.92-4.16
Upgrade
Other Investing Activities
-----13-3.27--
Upgrade
Investing Cash Flow
-87.95-1,909.47-90.69-98.14-166.89-103.37-266.8716.28-11.24-21.75
Upgrade
Share Issuance / Repurchase
4.028.799.3713.197.7314.2830.652.4715.6813.65
Upgrade
Debt Issued / Paid
-30.651,639-0.61-0.3600-75000
Upgrade
Other Financing Activities
-9.35-10.88-25.64-12.88-18.64-6.25----
Upgrade
Financing Cash Flow
-35.981,637-16.87-0.04-10.918.02-44.352.4715.6813.65
Upgrade
Exchange Rate Effect
3.16-9.48-3.252.85-0.23-10.161.790.22-8.28-8.45
Upgrade
Net Cash Flow
45.44-344.04156.73127.43-76.1154.71-155.01108.9260.3549.79
Upgrade
Free Cash Flow
74.03-160.47186.59128.54-4.0960.274.7465.3953.8548.75
Upgrade
Free Cash Flow Growth
--45.16%---19.46%14.31%21.42%10.46%5.34%
Upgrade
Free Cash Flow Margin
3.28%-7.04%14.18%10.11%-0.32%4.30%5.78%17.24%15.76%15.76%
Upgrade
Free Cash Flow Per Share
3.07-6.728.806.15-0.202.953.814.043.403.19
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).